Brand-name drug · GLP-1 receptor agonist

Byetta (exenatide)

From the FDA label, read Published by PepVault

Byetta is exenatide from AstraZeneca, a diabetes medicine injected from a pen twice a day, before the morning and evening meals.

FDA approved it, with diet and exercise, to improve blood sugar control in adults with type 2 diabetes.

Byetta’s marketing is ending: the product data on its label ends marketing of the 10 mcg pen on November 30, 2026 and of the 5 mcg pen on December 31, 2026. Drugs@FDA lists Byetta’s original application as discontinued, and a second Byetta application still as a prescription product.

Active ingredient
Exenatide
Maker
AstraZeneca
Class
GLP-1 receptor agonist
FDA application
NDA 021773, first approved 2005

What FDA approved it for

Byetta holds exenatide, so the label advises against using it with any other exenatide product.

It is a type 2 diabetes medicine only; it is not approved for children, and the label sets no weight-loss use.

From the label: 2.1 Recommended Dosing; 1 Indications and Usage; Product data (SPL).

How it is supplied

Byetta’s forms and the doses each one gives, as the label lists them
FormDoses
Prefilled pen, 5 mcg (60 doses)5 mcg
Prefilled pen, 10 mcg (60 doses)10 mcg

From the label: 3 Dosage Forms and Strengths.

The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

Byetta, twice a day

5 mcg10 mcgif needed
Byetta’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.
Byetta, twice a day: the steps on the label. Highest dose: 10 mcg twice a day.
DoseWhen, on the label
5 mcg twice a dayThe first month, within 60 minutes before the morning and evening meals
10 mcg twice a dayAfter 1 month, if blood sugar needs more

The month at 5 mcg is there to lower the chance of stomach side effects; the rise to 10 mcg twice a day depends on how blood sugar responds.

From the label: 2.1 Recommended Dosing.

How it’s taken

Each shot goes under the skin of the thigh, belly or upper arm within the hour before the morning and evening meals, or before the day’s two main meals at least about 6 hours apart. It is never taken after a meal, and the spot changes with every dose.

With insulin, Byetta is a separate shot and is never mixed with it; the two may go in the same area but not right next to each other. A Byetta pen is never shared between people, even with a new needle.

From the label: 2.1 Recommended Dosing.

A smiling woman in a dark training top in her kitchen, holding a glass of water

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

If a dose is missed

A missed Byetta dose is not made up: the schedule picks up with the next planned dose.

From the label: 2.1 Recommended Dosing.

Storage

A new Byetta pen is kept in the fridge at 36°F to 46°F, out of light and never frozen. After first use it can stay at up to 77°F, and the pen is thrown away 30 days after first use, even with medicine left.

From the label: 16.2 Storage and Handling.

Side effects and warnings

Adverse reactions in at least 2% of people on Byetta and more often than on placebo, three 30-week trials added to metformin and/or a sulfonylurea (963 on Byetta, 483 on placebo); hypoglycemia is counted separately. Percent of people.
ReactionPlacebo5 or 10 mcg twice a day
Nausea1844
Vomiting413
Diarrhea613
Feeling jittery49
Dizziness69
Headache69
Indigestion (dyspepsia)36
Weakness (asthenia)24

Nausea led the list and rose with the dose; for most people who had it, it grew milder and less frequent over time. It made 3% stop, and vomiting 1%.

Low blood sugar depended on the other medicines: added to a sulfonylurea, it came in 14.4% on 5 mcg and 35.7% on 10 mcg, against 3.3% on placebo; added to metformin alone, rates matched placebo.

The other warnings

Byetta has no boxed warning. Its warnings cover pancreatitis; low blood sugar with insulin or a sulfonylurea; kidney injury from fluid loss; severe stomach side effects (it is not for severe gastroparesis); antibodies that can blunt its effect; serious allergic reactions; a rare drop in platelets that can cause serious bleeding; gallbladder disease; and food entering the lungs under anesthesia.

From the label: 6.1 Clinical Trial Experience; 5 Warnings and Precautions.

What else we have on exenatide

Questions about Byetta

Is Byetta discontinued?

Its marketing is ending: the label’s product data ends the 10 mcg pen on November 30, 2026 and the 5 mcg pen on December 31, 2026. Drugs@FDA lists its original application as discontinued and a second Byetta application still as a prescription product.

What is the dose of Byetta?

The label starts at 5 mcg twice a day, within the hour before the morning and evening meals, and allows 10 mcg twice a day after 1 month if blood sugar needs it. A prescriber sets the dose.

Can Byetta be taken after a meal?

No. The label says it is taken in the 60 minutes before a meal and never after one.

What if a Byetta dose is missed?

It is skipped; the next planned dose is taken as usual.

How long does a Byetta pen last after first use?

It is thrown away 30 days after first use, even with medicine left in it; meanwhile it can be kept at up to 77°F.

Sources

PepVault is not affiliated with AstraZeneca. Byetta is a trademark of its owner.

PepVault for iPhone

Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo